Yokohama, Japan

Setsuko Hirose


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Yokohama, JP (1986)
  • Tachikawa, JP (1989)

Company Filing History:


Years Active: 1986-1989

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Setsuko Hirose

Introduction

Setsuko Hirose is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of chemistry, particularly in the development of novel compounds with various applications. With a total of 2 patents, her work has garnered attention in both industrial and agricultural sectors.

Latest Patents

Hirose's latest patents include innovative benzylamine derivatives. These derivatives possess a general formula that allows for their use in treating animal epidemics and infectious diseases caused by fungi. They serve as effective antimycotic agents for both humans and animals. Additionally, these compounds are valuable as agricultural fungicides for controlling plant diseases and as industrial fungicides for managing fungi and bacteria in various materials and products. Another notable patent involves microbiocidal imidazole derivatives, which are useful as industrial microbicides.

Career Highlights

Setsuko Hirose is currently employed at Mitsui Toatsu Chemicals, Incorporated, where she continues to advance her research and development efforts. Her work has been instrumental in creating solutions that address critical challenges in health and agriculture.

Collaborations

Hirose has collaborated with esteemed colleagues, including Kiyoshi Arai and Nobuo Komoto, to further enhance her research initiatives. These collaborations have played a vital role in the successful development of her patented innovations.

Conclusion

Setsuko Hirose's contributions to the field of chemistry through her innovative patents demonstrate her commitment to addressing significant challenges in health and agriculture. Her work continues to impact various industries positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…